Caplight Directory>Companies>Alivexis, Inc.-preview>Modulusdiscovery


Alivexis, Inc.

Alivexis, Inc.

Private
TokyoHealthcare & Life Scienceshttps://alivexis.com

Last Round

Series D

Mar 3, 2025

Total Funding Raised

$59.8M

Company Overview

Alivexis, Inc. is a biotechnology company that merges cutting-edge drug discovery platforms with disease biology expertise to develop a portfolio of small molecule drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

small molecule drug discoverycomputational drug discoveryAI drug discoverydrug discovery platformin silico drug discoverycomputer-aided drug designCADDdrug discovery servicesmolecular dynamicsphysics-based drug designtech-enabled CROdrug pipeline developmentdrug candidate out-licensingoncology drug discoveryrare disease therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alivexis, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alivexis, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DMar 3, 2025
Series DJan 7, 2025
Series CMar 1, 2022
Series BMay 13, 2020
Series AAug 9, 2018
View all Funding Rounds

Key People

Founding team and executive leadership

S. Roy Kimura

Founder, CEO Representative Director

Founding Team

Alivexis, Inc. Investors

Notable investors and investment history

InvestorRounds
JAFCO Group Co., Ltd.Series B
Mizuho CapitalSeries B
Heights Capital ManagementSeries C
Heights Capital ManagementSeries C
SBI HoldingsSeries C
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2025

    Will present at the GTC 2025 japan AI day event.

  • Mar 3, 2025

    $700K round completed.

View all signals

Alivexis, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alivexis, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alivexis, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range11
Year Founded2016
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.